Accueil - CRCL-OncoPharmacologie

Arnaud Colomb, Benoit Allignet, Mehdi Lamkhioued, Aurelie Swalduz, Lionel Falchero, et al.. Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer. Radiation Oncology, 2024, 19, ⟨10.1186/s13014-024-02553-z⟩. ⟨hal-04916129⟩
Benjamin Villalard, Arjan Boltjes, Florie Reynaud, Olivier Imbaud, Karine Thoinet, et al.. Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory. Nature Communications, 2024, 15 (1), pp.9570. ⟨10.1038/s41467-024-53776-3⟩. ⟨hal-04772741⟩
Jing Chen, Michal Sobecki, Ewelina Krzywinska, Kevin Thierry, Mélissa Masmoudi, et al.. Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas. EMBO Molecular Medicine, 2024, 16, pp.3033 - 3056. ⟨10.1038/s44321-024-00157-4⟩. ⟨hal-04916183⟩
Francesca Lucibello, Valérie Gounant, Mihaela Aldea, Michaël Duruisseaux, Maurice Perol, et al.. Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC. JTO Clinical and Research Reports, 2024, 6, ⟨10.1016/j.jtocrr.2024.100743⟩. ⟨hal-04916101⟩
Ali Chour, Anne-Claire Toffart, Elodie Berton, Michaël Duruisseaux. Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer. Frontiers in Oncology, 2024, 14, ⟨10.3389/fonc.2024.1328728⟩. ⟨hal-04728393⟩
Christophe Marquette, Laura Chastagnier, Benjamin da Sousa, Carlos Chocarro-Wrona, Edwin-Joffrey Courtial, et al.. Unlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting. Bioprinting , 2024, 41, pp.e00351. ⟨10.1016/j.bprint.2024.e00351⟩. ⟨hal-04729007⟩

Derniers manuscrits de l'équipe

Chiffres clés